176 related articles for article (PubMed ID: 17435182)
21. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
22. Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.
Kunes JP; Cordero-Koning KS; Lee LH; Lynch SM
Nutr Res; 2009 Feb; 29(2):114-22. PubMed ID: 19285602
[TBL] [Abstract][Full Text] [Related]
23. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
James RW; Deakin SP
Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
[TBL] [Abstract][Full Text] [Related]
24. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
[TBL] [Abstract][Full Text] [Related]
25. Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.
Blatter Garin MC; Moren X; James RW
J Lipid Res; 2006 Mar; 47(3):515-20. PubMed ID: 16327022
[TBL] [Abstract][Full Text] [Related]
26. PON1 arylesterase activity, HDL functionality and their correlation in malnourished children.
Mogarekar MR; Dhabe MG; Palmate MM
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):321-326. PubMed ID: 30875327
[TBL] [Abstract][Full Text] [Related]
27. The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase.
Otocka-Kmiecik A; Orłowska-Majdak M
Postepy Hig Med Dosw (Online); 2009 Dec; 63():668-77. PubMed ID: 20097953
[TBL] [Abstract][Full Text] [Related]
28. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.
Agirbasli M; Tanrikulu A; Erkus E; Azizy M; Sevim BA; Kaya Z; Taskin A; Aksoy N; Demirbag R
Acta Cardiol; 2014 Dec; 69(6):679-85. PubMed ID: 25643439
[TBL] [Abstract][Full Text] [Related]
29. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities.
Rock W; Rosenblat M; Miller-Lotan R; Levy AP; Elias M; Aviram M
J Agric Food Chem; 2008 Sep; 56(18):8704-13. PubMed ID: 18759451
[TBL] [Abstract][Full Text] [Related]
30. Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood.
Gugliucci A; Numaguchi M; Caccavello R; Kimura S
Redox Rep; 2014 May; 19(3):124-32. PubMed ID: 24620935
[TBL] [Abstract][Full Text] [Related]
31. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
32. The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity.
Kakafika AI; Xenofontos S; Tsimihodimos V; Tambaki AP; Lourida ES; Kalaitzidis R; Cariolou MA; Elisaf M; Tselepis AD
J Lipid Res; 2003 Oct; 44(10):1919-26. PubMed ID: 12867538
[TBL] [Abstract][Full Text] [Related]
33. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
Soran H; Schofield JD; Liu Y; Durrington PN
Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
[TBL] [Abstract][Full Text] [Related]
34. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
35. Associations between PON1 enzyme activities in human ovarian follicular fluid and serum specimens.
Kim K; Bloom MS; Fujimoto VY; Browne RW
PLoS One; 2017; 12(2):e0172193. PubMed ID: 28196109
[TBL] [Abstract][Full Text] [Related]
36. Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL.
Gugliucci A; Kinugasa E; Ogata H; Caccavello R; Kimura S
Clin Chim Acta; 2014 Mar; 430():9-14. PubMed ID: 24384301
[TBL] [Abstract][Full Text] [Related]
37. Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL.
Schilcher I; Stadler JT; Lechleitner M; Hrzenjak A; Berghold A; Pregartner G; Lhomme M; Holzer M; Korbelius M; Reichmann F; Springer A; Wadsack C; Madl T; Kratky D; Kontush A; Marsche G; Frank S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450841
[TBL] [Abstract][Full Text] [Related]
38. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
[TBL] [Abstract][Full Text] [Related]
39. Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion.
Aviram M; Vaya J
Curr Opin Lipidol; 2013 Aug; 24(4):339-44. PubMed ID: 23508039
[TBL] [Abstract][Full Text] [Related]
40. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
